Lamictal 2 mg žvečljive/disperzibilne tablete
Lamotrigin
General information
Drug nameLamictal 2 mg žvečljive/disperzibilne tablete
Medicine nameLamotrigin
National drug code3017016
PMS ID—
SNOMED descriptive name code—
Legal statusZdravilo z dovoljenjem za promet
Drug group—
OriginatorYes
Orphan drugNo
Marketing authorization
Procedure typePrenehanje veljavnosti dovoljenja za promet
No. and date of decision/certificate103-135/2021-3, 1. 2. 2022
Authorization validity date1. 2. 2022
Marketing end date1. 5. 2022
Application type—
Authorization/certificate holderGlaxoSmithKline Trading Services Limited
Drug safety monitoring
Additional safety monitoringNo
Precautionary measure/dispensing restrictions
Trigonik (relative driving prohibition).
Pregnancy prevention programmeNo
Controlled access programme(s)No
ATC codes
Route of administration
Route of administration name
Peroralna uporaba
Settlement data for compulsory health insurance billing
Substitute medicine
Preparation—
Valid from – to—
Clinical use data
Methods of use—
Indications—
Rounding factor—
DivisibleNo
Division for easier swallowingNo
Division for dosage adjustmentNo
Paediatric populationNo
Shortage actions
Substitute medicine in case of shortage - industrial medicine—
Substitute medicine in case of shortage - magistral or galenic medicine—
Prescribing restriction in case of drug shortageNo
Dispensing restriction in case of shortage or emergencyNo
Dispensing restriction for foreign prescriptions in case of shortage or emergencyNo
Export restrictionNo
Drug status
Trigonik (relative driving prohibition).
The medicinal product is present in wholesale distribution.
Last drug update date:9. 7. 2026